KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 6, 2017
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Sale
Common Stock
2017-01-05$6.16/sh−1,077$6,634→ 253,570 total
Footnotes (2)
- [F1]Sale of a total of 1,077 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 2,823 shares of restricted stock on January 4, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 170,041 shares of restricted stock.